Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Broder

Showing results (361-370 of 451) with videos related to

Pageof 46
Sort By:
Journal of Medical Economics|April 3, 2014
Cost effectiveness of a 92-gene assay for the diagnosis of metastatic cancerTanya G K Bentley, Brock E Schroeder, Catherine A Schnabel, et al.
Annals of Internal Medicine|April 1, 1984
NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virusS Broder, P A Bunn, E S Jaffe, et al.
Biochemical Pharmacology|June 1, 1987
Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivityD A Cooney, G Ahluwalia, H Mitsuya, et al.
Journal of Clinical Pharmacology|January 1, 1986
Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infectionJ M Collins, R W Klecker, R Yarchoan, et al.
Neurology and Therapy|May 27, 2020
The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims DataSheila R Reddy, Eunice Chang, Marian H Tarbox, et al.
Journal of Comparative Effectiveness Research|July 8, 2025
Clinical and economic burden among older adults with acromegaly in the United StatesTiffany P Quock, Eunice Chang, Ashis K Das, et al.
Journal of Comparative Effectiveness Research|August 29, 2025
Adherence, duration and healthcare costs in a real-world population of patients with acromegalyTiffany P Quock, Eunice Chang, Ashis K Das, et al.
Lancet (London, England)|September 1, 1990
Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complexR Yarchoan, J M Pluda, R V Thomas, et al.
Journal of Comparative Effectiveness Research|July 17, 2025
Dosing patterns, healthcare resource utilization and costs among acromegaly patients who consistently use lanreotide and injectable octreotideTiffany P Quock, Eunice Chang, Ashis K Das, et al.
The New England Journal of Medicine|June 26, 1980
X-linked hypogammaglobulinemia and isolated growth hormone deficiencyT A Fleisher, R M White, S Broder, et al.
Pageof 46

Showing results (361-370 of 451) with videos related to

Sort By:
Pageof 46
Journal of Medical Economics|April 3, 2014
Cost effectiveness of a 92-gene assay for the diagnosis of metastatic cancerTanya G K Bentley, Brock E Schroeder, Catherine A Schnabel, et al.
Annals of Internal Medicine|April 1, 1984
NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virusS Broder, P A Bunn, E S Jaffe, et al.
Biochemical Pharmacology|June 1, 1987
Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivityD A Cooney, G Ahluwalia, H Mitsuya, et al.
Journal of Clinical Pharmacology|January 1, 1986
Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infectionJ M Collins, R W Klecker, R Yarchoan, et al.
Neurology and Therapy|May 27, 2020
The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims DataSheila R Reddy, Eunice Chang, Marian H Tarbox, et al.
Journal of Comparative Effectiveness Research|July 8, 2025
Clinical and economic burden among older adults with acromegaly in the United StatesTiffany P Quock, Eunice Chang, Ashis K Das, et al.
Journal of Comparative Effectiveness Research|August 29, 2025
Adherence, duration and healthcare costs in a real-world population of patients with acromegalyTiffany P Quock, Eunice Chang, Ashis K Das, et al.
Lancet (London, England)|September 1, 1990
Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complexR Yarchoan, J M Pluda, R V Thomas, et al.
Journal of Comparative Effectiveness Research|July 17, 2025
Dosing patterns, healthcare resource utilization and costs among acromegaly patients who consistently use lanreotide and injectable octreotideTiffany P Quock, Eunice Chang, Ashis K Das, et al.
The New England Journal of Medicine|June 26, 1980
X-linked hypogammaglobulinemia and isolated growth hormone deficiencyT A Fleisher, R M White, S Broder, et al.
Pageof 46